奇正藏藥(002287.SZ):致力於成為永續發展的藏藥全產業鏈卓越企業
格隆匯6月16日丨有投資者向奇正藏藥(002287.SZ)提問:請再介紹一下公司2023-2025戰略及戰略目標。
奇正藏藥回覆:公司2023-2025年戰略為“雙輪驅動、雙翼領先、雙基保障”,致力於成為永續發展的藏藥全產業鏈卓越企業。
雙輪驅動是指營銷和研發的咬合式發展,其中營銷佔據了本戰略週期的龍頭地位,而研發的地位從上一個週期的戰略支持躍升到本週期的戰略核心。研發現代化首先是把傳統藏醫藥用現代人能夠聽得懂的語言説清楚、講明白;其次,對藏藥的臨牀研究、二次開發,可以支持公司走的更長遠;第三,高等級的循證醫學證據幫助公司以學術引領驅動營銷發展。研發現代化支持公司多產品發展,全域營銷包括醫院、藥店、線上等多渠道,滿足患者用藥的可及性。
雙翼領先是指資源和製造的整合式提升,其中資源保障進入戰略主項,而製造方面則提出了立志成為藏藥燈塔工廠的雄心。製造領先是在品質做到最好的基礎上不斷提高生產效率,藏藥炮製工藝標準化;資源領先是指穩定、可持續性的資源保障供應鏈,打造質量可靠、成本可控、多基地多渠道保障。
雙基保障是指發展數字化共享平台和激活組織的兩項重點工作,其中發展數字化共享平台的核心目標定為科學決策以提高公司整體運營效率,而激活組織旨在進行組織再造,從而解放生產力、提高領導力、培養並吸引高素質人才,作為戰略實現的重要支撐。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.